Tags: Drug.

Ceftobiprole (Zeftera/Zevtera) is a fifth-generation cephalosporin antibiotic with activity against methicillin-resistant Staphylococcus aureus penicillin-resistant Streptococcus pneumoniae Pseudomonas aeruginosa and enterococci. It was discovered by Basilea Pharmaceutica and was developed by Johnson & Johnson Pharmaceutical Research and Development.

Ceftobiprole2DCSD.svg
ATC prefix
J01
ATC suffix
DI01
CAS number
209467-52-7
CAS supplemental
(medocaril)
FDA UNII code
5T97333YZK
IUPAC name
(6R7R)-7-(2Z)-2-(5-amino-124-thiadiazol-3-ylidene)- 2-nitroso-1-oxoethyl]amino]-8-oxo-3-[(E)-[2-oxo-1-[(3R)- 3-pyrrolidinyl]-3-pyrrolidinylidene]methyl]-5-thia-1- azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
PubChem
6918430

Loading...

This page contains content from the copyrighted Wikipedia article "Ceftobiprole"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.